Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297201601> ?p ?o ?g. }
- W4297201601 endingPage "178" @default.
- W4297201601 startingPage "165" @default.
- W4297201601 abstract "Several clinical trials have reported that patients with cancer cachexia can benefit from n-3 polyunsaturated fatty acids (n-3 PUFAs) supplements; however, the results have been conflicting. This systematic review and meta-analysis aimed to evaluate the effect of n-3 PUFAs on cancer cachexia. A search of the PubMed, Embase, and Cochrane Library databases was performed to identify the included randomized controlled trials. Trials including patients with cancer cachexia who were administered a course of n-3 PUFAs were included. A meta-analysis on body weight, lean body weight, proinflammatory factors, quality of life, and median duration of survival was conducted. A total of 12 randomized controlled trials with 1184 patients were included. No effect on body weight (standard mean difference [SMD], 0.10; 95% CI, -0.06 to 0.26; P = .236), lean body weight (SMD, -0.17; 95% CI, -0.36 to 0.03, P = .095), or proinflammatory factors (interleukin-6: SMD, 0.31; 95% CI, -0.14 to 0.75; P = .18; tumor necrosis factor-α: SMD, -0.85; 95% CI, -2.39 to 0.69; P = .28) was observed. The use of n-3 PUFAs was associated with a significant improvement in quality of life (SMD, 0.70; 95% CI, 0.01-1.40; P = .048) and median duration of survival (median survival ratio, 1.10; 95% CI, 1.02-1.19; P = .014). For patients with cancer cachexia, our meta-analysis indicated that n-3 PUFAs improved quality of life and survival, but not body weight." @default.
- W4297201601 created "2022-09-27" @default.
- W4297201601 creator A5010805282 @default.
- W4297201601 creator A5012942693 @default.
- W4297201601 creator A5042572280 @default.
- W4297201601 creator A5078264850 @default.
- W4297201601 date "2022-11-01" @default.
- W4297201601 modified "2023-10-12" @default.
- W4297201601 title "Omega-3 polyunsaterated fatty acids improve quality of life and survival, but not body weight in cancer cachexia: A systematic review and meta-analysis of controlled trials" @default.
- W4297201601 cites W1275357281 @default.
- W4297201601 cites W1579998928 @default.
- W4297201601 cites W1842215792 @default.
- W4297201601 cites W1865608113 @default.
- W4297201601 cites W1908242390 @default.
- W4297201601 cites W1965062785 @default.
- W4297201601 cites W1973767788 @default.
- W4297201601 cites W1979666460 @default.
- W4297201601 cites W1985534077 @default.
- W4297201601 cites W1989227483 @default.
- W4297201601 cites W1995766936 @default.
- W4297201601 cites W2007624126 @default.
- W4297201601 cites W2009901885 @default.
- W4297201601 cites W2019348878 @default.
- W4297201601 cites W2020950228 @default.
- W4297201601 cites W2026616886 @default.
- W4297201601 cites W2034407197 @default.
- W4297201601 cites W2048001109 @default.
- W4297201601 cites W2057348394 @default.
- W4297201601 cites W2060205138 @default.
- W4297201601 cites W2061947082 @default.
- W4297201601 cites W2063320860 @default.
- W4297201601 cites W2064824453 @default.
- W4297201601 cites W2072884377 @default.
- W4297201601 cites W2073560422 @default.
- W4297201601 cites W2078608486 @default.
- W4297201601 cites W2090418019 @default.
- W4297201601 cites W2107251975 @default.
- W4297201601 cites W2109956558 @default.
- W4297201601 cites W2111857880 @default.
- W4297201601 cites W2121911732 @default.
- W4297201601 cites W2126536849 @default.
- W4297201601 cites W2134032880 @default.
- W4297201601 cites W2145280166 @default.
- W4297201601 cites W2154055686 @default.
- W4297201601 cites W2163227456 @default.
- W4297201601 cites W2166943264 @default.
- W4297201601 cites W2174795486 @default.
- W4297201601 cites W2290301118 @default.
- W4297201601 cites W2316349176 @default.
- W4297201601 cites W2409926011 @default.
- W4297201601 cites W2411212518 @default.
- W4297201601 cites W2470158267 @default.
- W4297201601 cites W2480421002 @default.
- W4297201601 cites W2505149831 @default.
- W4297201601 cites W2626721982 @default.
- W4297201601 cites W2734044068 @default.
- W4297201601 cites W2784374589 @default.
- W4297201601 cites W2789895790 @default.
- W4297201601 cites W2794215959 @default.
- W4297201601 cites W2799336826 @default.
- W4297201601 cites W2898569492 @default.
- W4297201601 cites W2902161659 @default.
- W4297201601 cites W2902884328 @default.
- W4297201601 cites W2916622467 @default.
- W4297201601 cites W2961054607 @default.
- W4297201601 cites W3199615173 @default.
- W4297201601 cites W3205327980 @default.
- W4297201601 cites W4239694314 @default.
- W4297201601 doi "https://doi.org/10.1016/j.nutres.2022.09.009" @default.
- W4297201601 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36283229" @default.
- W4297201601 hasPublicationYear "2022" @default.
- W4297201601 type Work @default.
- W4297201601 citedByCount "2" @default.
- W4297201601 countsByYear W42972016012023 @default.
- W4297201601 crossrefType "journal-article" @default.
- W4297201601 hasAuthorship W4297201601A5010805282 @default.
- W4297201601 hasAuthorship W4297201601A5012942693 @default.
- W4297201601 hasAuthorship W4297201601A5042572280 @default.
- W4297201601 hasAuthorship W4297201601A5078264850 @default.
- W4297201601 hasConcept C121608353 @default.
- W4297201601 hasConcept C126322002 @default.
- W4297201601 hasConcept C159110408 @default.
- W4297201601 hasConcept C164027704 @default.
- W4297201601 hasConcept C168563851 @default.
- W4297201601 hasConcept C19038510 @default.
- W4297201601 hasConcept C2776478404 @default.
- W4297201601 hasConcept C2776914184 @default.
- W4297201601 hasConcept C2777704314 @default.
- W4297201601 hasConcept C2779951463 @default.
- W4297201601 hasConcept C3017894415 @default.
- W4297201601 hasConcept C511355011 @default.
- W4297201601 hasConcept C543025807 @default.
- W4297201601 hasConcept C544821477 @default.
- W4297201601 hasConcept C55493867 @default.
- W4297201601 hasConcept C71924100 @default.
- W4297201601 hasConcept C86803240 @default.
- W4297201601 hasConcept C90924648 @default.
- W4297201601 hasConcept C95190672 @default.